サマリー

尿素サイクル障害治療の世界市場 2023-2027
尿素サイクル障害治療市場は、2022-2027年に2億3,550万米ドルの成長が予測され、予測期間中のCAGRは3.57%で加速すると予測されます。当レポートでは、尿素サイクル障害治療市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。尿素サイクル障害の有病率の増加、高齢者患者の増加、戦略的イニシアティブへの注目の高まりが市場を牽引しています。
Technavio社の尿素サイクル障害治療市場は以下のように分類されます：
治療法別
- フェニル酪酸グリセロール
- フェニル酪酸ナトリウム
- アミノ酸サプリメント
- 安息香酸ナトリウム
- その他
投与経路別
- 経口剤
- 注射剤
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間の尿素サイクル障害治療市場の成長を促進する主な理由の一つとして、新興国における成長可能性の増大を挙げています。また、新興国での早期スクリーニングと診断に関する技術的進歩の増加、コンパニオン診断のニーズの高まりは、尿素サイクル障害の診断と治療に大きな需要をもたらすでしょう。
尿素サイクル障害治療市場に関する本レポートでは、以下の分野をカバーしています：
- 尿素サイクル障害治療市場規模
- 尿素サイクル障害治療市場予測
- 尿素サイクル障害治療市場産業分析
堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、本レポートでは、Abbott Laboratories社、Acer Therapeutics Inc.社、Aeglea BioTherapeutics Inc.社、Arcturus Therapeutics Holdings Inc、Bausch Health Co. Inc.、Boehringer Ingelheim International GmbH、CAMP4、Dipharma SA、Eurocept B.V.、Horizon Therapeutics Plc、Immedica Pharma AB、Medunik USA、Nestle SA、Orpharma Pty Ltd.、Reckitt Benckiser Group Plc、Recordati S.p.A.、RELIEF THERAPEUTICS Holding SA、Swedish Orphan Biovitrum AB、Synlogic Inc.、Ultragenyx Pharmaceutical Inc.などです。また、尿素サイクル障害治療市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/urea-cycle-disorder-treatment-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global urea cycle disorder treatment market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global urea cycle disorder treatment market 2017 - 2021 ($ million)
o 4.2 Therapy Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
o 4.3 Route of Administration Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Therapy
o 6.1 Market segments
o Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)
o 6.2 Comparison by Therapy
o Exhibit 32: Chart on Comparison by Therapy
o Exhibit 33: Data Table on Comparison by Therapy
o 6.3 Glycerol phenylbutyrate - Market size and forecast 2022-2027
o Exhibit 34: Chart on Glycerol phenylbutyrate - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Glycerol phenylbutyrate - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Glycerol phenylbutyrate - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Glycerol phenylbutyrate - Year-over-year growth 2022-2027 (%)
o 6.4 Sodium phenylbutyrate - Market size and forecast 2022-2027
o Exhibit 38: Chart on Sodium phenylbutyrate - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Sodium phenylbutyrate - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Sodium phenylbutyrate - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Sodium phenylbutyrate - Year-over-year growth 2022-2027 (%)
o 6.5 Amino acid supplements - Market size and forecast 2022-2027
o Exhibit 42: Chart on Amino acid supplements - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Amino acid supplements - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Amino acid supplements - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Amino acid supplements - Year-over-year growth 2022-2027 (%)
o 6.6 Sodium benzoate - Market size and forecast 2022-2027
o Exhibit 46: Chart on Sodium benzoate - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Sodium benzoate - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Sodium benzoate - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Sodium benzoate - Year-over-year growth 2022-2027 (%)
o 6.7 Others - Market size and forecast 2022-2027
o Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Therapy
o Exhibit 54: Market opportunity by Therapy ($ million)
o Exhibit 55: Data Table on Market opportunity by Therapy ($ million)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 56: Chart on Route of Administration - Market share 2022-2027 (%)
o Exhibit 57: Data Table on Route of Administration - Market share 2022-2027 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 58: Chart on Comparison by Route of Administration
o Exhibit 59: Data Table on Comparison by Route of Administration
o 7.3 Oral - Market size and forecast 2022-2027
o Exhibit 60: Chart on Oral - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Oral - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Oral - Year-over-year growth 2022-2027 (%)
o 7.4 Injectables - Market size and forecast 2022-2027
o Exhibit 64: Chart on Injectables - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Injectables - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Injectables - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Injectables - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 68: Market opportunity by Route of Administration ($ million)
o Exhibit 69: Data Table on Market opportunity by Route of Administration ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 119: Abbott Laboratories - Overview
o Exhibit 120: Abbott Laboratories - Business segments
o Exhibit 121: Abbott Laboratories - Key news
o Exhibit 122: Abbott Laboratories - Key offerings
o Exhibit 123: Abbott Laboratories - Segment focus
o 12.4 Acer Therapeutics Inc.
o Exhibit 124: Acer Therapeutics Inc. - Overview
o Exhibit 125: Acer Therapeutics Inc. - Product / Service
o Exhibit 126: Acer Therapeutics Inc. - Key offerings
o 12.5 Aeglea BioTherapeutics Inc.
o Exhibit 127: Aeglea BioTherapeutics Inc. - Overview
o Exhibit 128: Aeglea BioTherapeutics Inc. - Product / Service
o Exhibit 129: Aeglea BioTherapeutics Inc. - Key offerings
o 12.6 Arcturus Therapeutics Holdings Inc.
o Exhibit 130: Arcturus Therapeutics Holdings Inc. - Overview
o Exhibit 131: Arcturus Therapeutics Holdings Inc. - Product / Service
o Exhibit 132: Arcturus Therapeutics Holdings Inc. - Key offerings
o 12.7 Bausch Health Co. Inc.
o Exhibit 133: Bausch Health Co. Inc. - Overview
o Exhibit 134: Bausch Health Co. Inc. - Business segments
o Exhibit 135: Bausch Health Co. Inc. - Key news
o Exhibit 136: Bausch Health Co. Inc. - Key offerings
o Exhibit 137: Bausch Health Co. Inc. - Segment focus
o 12.8 Boehringer Ingelheim International GmbH
o Exhibit 138: Boehringer Ingelheim International GmbH - Overview
o Exhibit 139: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 140: Boehringer Ingelheim International GmbH - Key news
o Exhibit 141: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 142: Boehringer Ingelheim International GmbH - Segment focus
o 12.9 CAMP4
o Exhibit 143: CAMP4 - Overview
o Exhibit 144: CAMP4 - Product / Service
o Exhibit 145: CAMP4 - Key offerings
o 12.10 Eurocept B.V.
o Exhibit 146: Eurocept B.V. - Overview
o Exhibit 147: Eurocept B.V. - Product / Service
o Exhibit 148: Eurocept B.V. - Key offerings
o 12.11 Horizon Therapeutics Plc
o Exhibit 149: Horizon Therapeutics Plc - Overview
o Exhibit 150: Horizon Therapeutics Plc - Business segments
o Exhibit 151: Horizon Therapeutics Plc - Key news
o Exhibit 152: Horizon Therapeutics Plc - Key offerings
o Exhibit 153: Horizon Therapeutics Plc - Segment focus
o 12.12 Medunik USA
o Exhibit 154: Medunik USA - Overview
o Exhibit 155: Medunik USA - Product / Service
o Exhibit 156: Medunik USA - Key offerings
o 12.13 Orpharma Pty Ltd.
o Exhibit 157: Orpharma Pty Ltd. - Overview
o Exhibit 158: Orpharma Pty Ltd. - Product / Service
o Exhibit 159: Orpharma Pty Ltd. - Key offerings
o 12.14 Recordati S.p.A
o Exhibit 160: Recordati S.p.A - Overview
o Exhibit 161: Recordati S.p.A - Business segments
o Exhibit 162: Recordati S.p.A - Key offerings
o Exhibit 163: Recordati S.p.A - Segment focus
o 12.15 RELIEF THERAPEUTICS Holding SA
o Exhibit 164: RELIEF THERAPEUTICS Holding SA - Overview
o Exhibit 165: RELIEF THERAPEUTICS Holding SA - Product / Service
o Exhibit 166: RELIEF THERAPEUTICS Holding SA - Key offerings
o 12.16 Synlogic Inc.
o Exhibit 167: Synlogic Inc. - Overview
o Exhibit 168: Synlogic Inc. - Product / Service
o Exhibit 169: Synlogic Inc. - Key offerings
o 12.17 Ultragenyx Pharmaceutical Inc.
o Exhibit 170: Ultragenyx Pharmaceutical Inc. - Overview
o Exhibit 171: Ultragenyx Pharmaceutical Inc. - Product / Service
o Exhibit 172: Ultragenyx Pharmaceutical Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 173: Inclusions checklist
o Exhibit 174: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 175: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 176: Research methodology
o Exhibit 177: Validation techniques employed for market sizing
o Exhibit 178: Information sources
o 13.5 List of abbreviations
o Exhibit 179: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global urea cycle disorder treatment market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy
Exhibits33: Data Table on Comparison by Therapy
Exhibits34: Chart on Glycerol phenylbutyrate - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Glycerol phenylbutyrate - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Glycerol phenylbutyrate - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Glycerol phenylbutyrate - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Sodium phenylbutyrate - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Sodium phenylbutyrate - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Sodium phenylbutyrate - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Sodium phenylbutyrate - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Amino acid supplements - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Amino acid supplements - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Amino acid supplements - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Amino acid supplements - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Sodium benzoate - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Sodium benzoate - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Sodium benzoate - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Sodium benzoate - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Therapy ($ million)
Exhibits55: Data Table on Market opportunity by Therapy ($ million)
Exhibits56: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits57: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Route of Administration
Exhibits59: Data Table on Comparison by Route of Administration
Exhibits60: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Injectables - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Injectables - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Injectables - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Injectables - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Route of Administration ($ million)
Exhibits69: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Abbott Laboratories - Overview
Exhibits120: Abbott Laboratories - Business segments
Exhibits121: Abbott Laboratories - Key news
Exhibits122: Abbott Laboratories - Key offerings
Exhibits123: Abbott Laboratories - Segment focus
Exhibits124: Acer Therapeutics Inc. - Overview
Exhibits125: Acer Therapeutics Inc. - Product / Service
Exhibits126: Acer Therapeutics Inc. - Key offerings
Exhibits127: Aeglea BioTherapeutics Inc. - Overview
Exhibits128: Aeglea BioTherapeutics Inc. - Product / Service
Exhibits129: Aeglea BioTherapeutics Inc. - Key offerings
Exhibits130: Arcturus Therapeutics Holdings Inc. - Overview
Exhibits131: Arcturus Therapeutics Holdings Inc. - Product / Service
Exhibits132: Arcturus Therapeutics Holdings Inc. - Key offerings
Exhibits133: Bausch Health Co. Inc. - Overview
Exhibits134: Bausch Health Co. Inc. - Business segments
Exhibits135: Bausch Health Co. Inc. - Key news
Exhibits136: Bausch Health Co. Inc. - Key offerings
Exhibits137: Bausch Health Co. Inc. - Segment focus
Exhibits138: Boehringer Ingelheim International GmbH - Overview
Exhibits139: Boehringer Ingelheim International GmbH - Business segments
Exhibits140: Boehringer Ingelheim International GmbH - Key news
Exhibits141: Boehringer Ingelheim International GmbH - Key offerings
Exhibits142: Boehringer Ingelheim International GmbH - Segment focus
Exhibits143: CAMP4 - Overview
Exhibits144: CAMP4 - Product / Service
Exhibits145: CAMP4 - Key offerings
Exhibits146: Eurocept B.V. - Overview
Exhibits147: Eurocept B.V. - Product / Service
Exhibits148: Eurocept B.V. - Key offerings
Exhibits149: Horizon Therapeutics Plc - Overview
Exhibits150: Horizon Therapeutics Plc - Business segments
Exhibits151: Horizon Therapeutics Plc - Key news
Exhibits152: Horizon Therapeutics Plc - Key offerings
Exhibits153: Horizon Therapeutics Plc - Segment focus
Exhibits154: Medunik USA - Overview
Exhibits155: Medunik USA - Product / Service
Exhibits156: Medunik USA - Key offerings
Exhibits157: Orpharma Pty Ltd. - Overview
Exhibits158: Orpharma Pty Ltd. - Product / Service
Exhibits159: Orpharma Pty Ltd. - Key offerings
Exhibits160: Recordati S.p.A - Overview
Exhibits161: Recordati S.p.A - Business segments
Exhibits162: Recordati S.p.A - Key offerings
Exhibits163: Recordati S.p.A - Segment focus
Exhibits164: RELIEF THERAPEUTICS Holding SA - Overview
Exhibits165: RELIEF THERAPEUTICS Holding SA - Product / Service
Exhibits166: RELIEF THERAPEUTICS Holding SA - Key offerings
Exhibits167: Synlogic Inc. - Overview
Exhibits168: Synlogic Inc. - Product / Service
Exhibits169: Synlogic Inc. - Key offerings
Exhibits170: Ultragenyx Pharmaceutical Inc. - Overview
Exhibits171: Ultragenyx Pharmaceutical Inc. - Product / Service
Exhibits172: Ultragenyx Pharmaceutical Inc. - Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations